Rengalin, 100 ml

It was shown experimentally that the drug components modify the activity of ligand-receptor interaction of endogenous regulators with the corresponding receptors: antibodies to morphine – with opiate receptors; antibodies to histamine – with H1-histamine receptors; antibodies to bradykinin – with B1-bradykinin receptors; the combined use of components leads to a stronger anti-cough effect.

In addition to the anti-coughing effect, the complex drug due to its components has anti-inflammatory, anti-edema, anti-allergic, antispasmodic (antibodies to histamine, antibodies to bradykinin) and analgesic effect (antibodies to morphine).

Complex preparation Rengalin due to modification of histamine-dependent activation of H1-receptors and bradykinin-dependent activation of B2-receptors selectively decreases excitability of the medulla oblongata cough center and inhibits central links of the cough reflex. Inhibiting centers of pain sensitivity in the thalamus, blocks the transmission of pain impulses to the cerebral cortex. Inhibits the flow of pain impulses from the periphery by reducing the release of tissue and plasma algogens (histamine, bradykinin, prostaglandins, etc.). Unlike narcotic analgesics it does not cause respiratory depression, drug addiction, has no narcogenic and hypnotic effect.

Relieves symptoms of acute pharyngitis, laryngitis and bronchitis, reducing bronchospasm. Cures systemic and local symptoms of allergic reactions due to the effect on the synthesis and release of histamine and bradykinin from mast cells.

Indications

Active ingredient

Composition

How to take, the dosage

Interaction

Special Instructions

Synopsis

Contraindications

Side effects

Overdose

Pregnancy use

Similarities